Tafasitamab plus lenalidomide and R-CHOP delays disease progression in aggressive B-cell lymphomas

Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard of care in triple-negative breast cancer

Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma

ASCO 2026: Breast cancer overview

Combination therapeutic strategies for aRCC patients with bone metastases

Perioperative anti–PD-L1 therapy improves event-free survival in resectable NSCLC with ctDNA-based risk stratification

Denikitug shows immune activation and early anti-tumour activity in advanced solid tumour

Zedoresertib plus lunresertib shows promising tumour shrinkage in CCNE1-amplified and FBXW7-mutant cancers

The potential of T-cell engagers in SCLC treatment

EAU 2026: Updates in NMIBC

Enzalutamide plus radium-223 extends survival in bone metastatic prostate cancer

ASCO GU 2026: Updates in renal cancer